mecaib
Bluelighter
Hello,
The title pretty much sums up my question.
If one of the primary neuroprotective effects of NMDA antagonists is to prevent glutamic acid-aided excitoxity in the brain, then what happens to all the glutamate in the mean time? Is it sitting there, waiting to taken back up by the NMDA receptors? Does it go anywhere? Is it possible that NMDA antagonists, by delaying the reuptake of glutamic acid, actually cause a dangerous rebound effect because the glutamate had nowhere else to go?
I would appreciate a response. A link to some research findings would be even better. Thanks in advance~
edit: Ok, I found out that Glutamate Transporters ferry the excess glutamate away from extracellular space, where it can build up and become toxic under certain conditions. It would appear that adenosine triphosphate, oxygen, and proper blood flow facilitate this action.
My question about a possible rebound effect still stands. Could temporary antagonism of NMDA receptor activity result in an accumulation of glutamate because the glutamate transporters cannot work fast enough?
Also, Is it possible that NMDA antagonism, over time, might actually result in a more efficient glutamate transportation system because the glutamate is not always being taken in by the NMDA receptors and it has to go somewhere?
The title pretty much sums up my question.
If one of the primary neuroprotective effects of NMDA antagonists is to prevent glutamic acid-aided excitoxity in the brain, then what happens to all the glutamate in the mean time? Is it sitting there, waiting to taken back up by the NMDA receptors? Does it go anywhere? Is it possible that NMDA antagonists, by delaying the reuptake of glutamic acid, actually cause a dangerous rebound effect because the glutamate had nowhere else to go?
I would appreciate a response. A link to some research findings would be even better. Thanks in advance~
edit: Ok, I found out that Glutamate Transporters ferry the excess glutamate away from extracellular space, where it can build up and become toxic under certain conditions. It would appear that adenosine triphosphate, oxygen, and proper blood flow facilitate this action.
My question about a possible rebound effect still stands. Could temporary antagonism of NMDA receptor activity result in an accumulation of glutamate because the glutamate transporters cannot work fast enough?
Also, Is it possible that NMDA antagonism, over time, might actually result in a more efficient glutamate transportation system because the glutamate is not always being taken in by the NMDA receptors and it has to go somewhere?
Last edited: